Please join us for The Stanford Gynecologic Oncology Research Symposium. This event will provide an update on the latest scientific advances in the field and bring together and encourage collaborative research with physicians and scientists throughout the world. The symposium will present emerging research and advances in gynecologic oncology, with a focus on ovarian and breast cancer. Experts will explore topics including genetic testing, immunotherapy, organoid modeling, computational biology, and novel clinical trial data. Designed for oncology professionals, the activity will enhance understanding of the genomic landscape, therapeutic resistance, and precision medicine approaches. Attendees will gain actionable insights to support evidence-based treatment planning and improved patient outcomes in gynecologic oncology practice.

Registration
Registration is free. Please use the Register tab above or this link to the registration website: https://med.stanford.edu/cancer/about/events/the-first-annual--stanford-gynecologic-oncology-research-symposium.html

Credits
AMA PRA Category 1 Credits™ (8.00 hours), ANCC Contact Hours (8.00 hours), CA BRN - California Board of Registered Nurses Contact Hours (8.00 hours), Non-Physician Participation Credit (8.00 hours)

Target Audience
Specialties - Gynecologic Oncology, Obstetrics & Gynecology, Oncology

Professions - Fellow/Resident, Non-Physician, Nurse, Physician, Registered Nurse (RN), Student

Objectives
At the conclusion of this activity, learners should be able to:

• Summarize recent advances in the genomic and molecular profiling of ovarian and other gynecologic cancers.
• Evaluate the role and clinical application of immunotherapy, including CAR-T cell therapy, in gynecologic oncology.
• Apply principles of precision medicine and genetic testing to the management of women’s cancers.
• Discuss the relevance of organoid and computational models in cancer research and therapeutic development.
• Identify clinical trial opportunities and strategies for addressing treatment resistance in gynecologic cancers.

Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this live activity for a maximum of 8.0 ANCC contact hours.

California Board of Registered Nursing (CA BRN)
Stanford Medicine Provider approved by the California Board of Registered Nursing, Provider Number 17874, for 8.0 contact hours.